Glucose Health, Inc (GLUC) financial statements (2021 and earlier)

Company profile

Business Address 609 SW 8TH STREET
BENTONVILLE, AR 72712
State of Incorp. NV
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments171892124282
Cash and cash equivalents171892124282
Receivables991012121683
Inventory, net of allowances, customer advances and progress billings    688
Inventory    688
Prepaid expense0  12238
Other undisclosed current assets    000
Total current assets:262719334420751
Noncurrent Assets
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Deferred costs  (0)    
Other undisclosed noncurrent assets  0    
Total noncurrent assets:0000000
TOTAL ASSETS:262719334420752
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:789815213812416995
Accrued liabilities4138395   
Interest and dividends payable    3327 
Other undisclosed accounts payable and accrued liabilities37601131339114395
Debt10155395366
Due to related parties35353511235  
Other undisclosed current liabilities329328350240253218354
Total current liabilities:453477542529418424455
Noncurrent Liabilities
Total liabilities:453477542529418424455
Stockholders' equity
Stockholders' equity attributable to parent, including:(426)(449)(524)(495)(374)(217)(403)
Preferred stock113113113113113113113
Common stock5433333
Common stock, value, subscriptions23232323232323
Additional paid in capital5,7175,7135,6891205,6865,6825,400
Accumulated other comprehensive loss(75)(75)(75)(75)(75)(75)(75)
Accumulated deficit(6,209)(6,227)(6,277)(6,248)(6,124)(5,963)(5,866)
Other undisclosed stockholders' equity attributable to parent   5,568   
Total stockholders' equity:(426)(449)(524)(495)(374)(217)(403)
TOTAL LIABILITIES AND EQUITY:262719334420752

Income statement (P&L) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Revenues
(Revenue, Net)
2434151522960
Cost of revenue(1)(0)(15)(15)(5)(274)(0)
Cost of goods and services sold    (5)(274)(0)
Gross profit:233400(3)210
Operating expenses(18)(18)(29)(25)(53)(15)(12)
Operating income (loss):516(28)(25)(56)6(12)
Nonoperating income (expense)1433(1)(99)(105)(93)(17)
Interest and debt expense(6)(5)(1)(99)(105)(93)(17)
Income (loss) from continuing operations before equity method investments, income taxes:1344(30)(223)(266)(181)(46)
Other undisclosed income from continuing operations before income taxes651991059317
Net income (loss) available to common stockholders, diluted:1949(29)(124)(161)(87)(29)

Comprehensive Income ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Net income (loss):1949(29)(124)(161)(87)(29)
Comprehensive income (loss), net of tax, attributable to parent:1949(29)(124)(161)(87)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: